Skip to main content
. 2016 Jan;18(1):100–108. doi: 10.1016/j.jmoldx.2015.08.003

Figure 3.

Figure 3

Circulating levels of BRAFV600E by pathologic diagnosis (benign, left; malignant, right) and tissue mutational status. Benign/BRAF indicates a tumor that was read as either an adenoma or a benign hyperplastic lesion that is also negative for BRAFV600E by conventional tissue testing. Benign/BRAF+ indicates pathologically negative, tissue BRAFV600E+. Asterisk indicates patients with known distant metastatic disease.